Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sowoon Choi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Hye-Young Youn

    Natural Product Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea

    1 shared publication
  • Kwang Hyun Cha

    Center for Natural Product Systems Biology, Korea Institute of Science and Technology (KIST), Gangneung, 25451, Republic of Korea.

    1 shared publication
  • Myungsuk Kim

    Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), Gangneung, Republic of Korea

    1 shared publication
  • Ngoc Bao Nguyen

    Natural Product Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea

    1 shared publication
  • Sang Hoon Jung

    Center for Natural Product Efficacy Optimization, Korea Institute of Science and Technology (KIST), Institute of Natural Products, Gangneung 25451, Republic of Korea; Natural Product Applied Science, KIST School, University of Science and Technology (UST), Gangneung 25451, Republic of Korea

    1 shared publication
  • Suk Woo Kang

    Research School of Chemistry Australian National University Canberra ACT 2601 Australia

    1 shared publication

Latest Publications

  • Open Access

    Cornflower Extract and Its Active Components Alleviate Dexamethasone-Induced Muscle Wasting by Targeting Cannabinoid Receptors and Modulating Gut Microbiota

    by Ngoc Bao Nguyen, Tam Thi Le, Suk Woo Kang, Kwang Hyun Cha, Sowoon Choi, Hye-Young Youn, Sang Hoon Jung, Myungsuk Kim

    Sarcopenia, a decline in muscle mass and strength, can be triggered by aging or medications like glucocorticoids. This study investigated cornflower (Centaurea cyanus) water extract (CC) as a potential protective agent against DEX-induced muscle wasting in vitro and in vivo. CC and its isolated compounds mitigated oxidative stress, promoted myofiber growth, and boosted ATP production in C2C12 myotubes. Mechanistically, CC reduced protein degradation markers, increased mitochondrial content, and activated protein synthesis signaling. Docking analysis suggested cannabinoid receptors (CB) 1 and 2 as potential targets of CC compounds. Specifically, graveobioside A from CC inhibited CB1 and upregulated CB2, subsequently stimulating protein synthesis and suppressing degradation. In vivo, CC treatment attenuated DEX-induced muscle wasting, as evidenced by enhanced grip strength, exercise performance, and modulation of muscle gene expression related to differentiation, protein turnover, and exercise performance. Moreover, CC enriched gut microbial diversity, and the abundance of Clostridium sensu stricto 1 positively correlated with muscle mass. These findings suggest a multifaceted mode of action for CC: (1) direct modulation of the muscle cannabinoid receptor system favoring anabolic processes and (2) indirect modulation of muscle health through the gut microbiome. Overall, CC presents a promising therapeutic strategy for preventing and treating muscle atrophy.